The name, mechanism of action, and reference of the drugs discussed above.

Serial	Drug	Mechanism of action	Reference
1	Galantamine	AChEI	62
2	Donepezil	AChEI	62
3	Rivastigmine	AChEI and BChEI	63
4	Tacrine	AChEI and BChEI	65
5	Metrifonate	Irreversible AChEI and BChEI	64
6	ABT-126	Selective α7 nicotinic receptor agonist	72
7	ABT-089	Selective α4β2 nicotinic partial agonist	75
8	Oxotremorine	CNS muscarinic agonist	77
9	Xanomeline	CNS muscarinic agonist	79
10	EUK1001	CNS muscarinic agonist	79
11	Memantine	NMDA antagonist	82
12	Phencyclidine	NMDA antagonist	86
13	Vinpocetine	PDE1 inhibitor	89
14	Cilostazol	PDE3 inhibitor	87
15	HT-0712	PDE4 inhibitor	96
16	Roflumilast	PDE4 inhibitor	96
17	Zatolmilast (BPN14770)	PDE4 inhibitor	96
18	Denbufylline	PDE4 inhibitor	99
19	Sildenafil	PDE5 inhibitor	87 and 96
20	BI-409306	PDE9 inhibitor	100 and 101
21	PF-04447943	PDE9 inhibitor	100 and 101
22	Propentofylline	Broad-spectrum PDE inhibitor	87
23	Aducanumab	Selective anti-Aβ monoclonal antibody	108–112
24	Lecanemab	Selective anti-Aβ monoclonal antibody	113–116
25	Solanezumab	Monoclonal anti-Aβ antibody	118 and 119
26	Bapineuzumab	Monoclonal anti-Aβ antibody	120 and 121
27	Ponezumab	Monoclonal anti-Aβ antibody	122
28	Gantenerumab	Monoclonal anti-Aβ antibody	119
29	AN1792	Purified Aβ-42 polypeptide vaccine	125
30	ACC-001	N-terminal Aβ1-7 vaccine	57
31	QS-21	Adjuvant combined with ACC-001	129 and 130
32	ABvac40	C-terminal end of Aβ40 vaccine	57
33	Tramiprosate	Inhibitor for Aβ42 oligomer formation	133–136
34	Valitramiprosate (ALZ-801)	Inhibitor for Aβ42 oligomer formation (prodrug)	133
35	Sodium selenate	PP2A activator	140
36	Methylthioninium chloride	PP2A activator	142
37	Tideglusib	GSK3β inhibitor	145 and 146
38	Lithium chloride	GSK3β inhibitor	150
39	LY2811376	BACE-1 inhibitor	151
40	LY2886721	BACE-1 inhibitor	16 and 153
41	Umibecestat (CNP520)	BACE-1 inhibitor	155
42	Verubecestat (MK8931)	BACE-1 inhibitor	158 and 159
43	Atabecestat (JNJ-54861911)	BACE-1 inhibitor	161–163
44	Lanabecestat	BACE-1 inhibitor	167
45	Elenbecestat (E2609)	BACE-1 inhibitor	169
46	NB-360	Dual BACE-1 and BACE-2 inhibitor	171
47	RG712	Dual BACE-1 and BACE-2 inhibitor	174
48	Semagacestat (LY450139)	γ-Secretase inhibitor	178
49	MK-0752	γ-Secretase inhibitor	154
50	Avagacestat (BMS-708163)	Selective γ-secretase inhibitor	182
51	Begacestat (GSI-953)	Selective γ-secretase inhibitor	186
52	PF-3084014	Notch sparing γ-secretase inhibitor	189 and 190
53	Ibuprofen	First generation GSM	194 and 195
54	Indomethacin	First generation GSM	194 and 195
55	Sulindac	First generation GSM	194 and 195
56	Tarenflurbil	Second generation GSM	197
57	JNJ-40418677	Second generation GSM	202
58	EVP-0015962	Second generation GSM	203
59	Itanapraced (CHF5074)	Second generation GSM	205
60	BIIB042	Second generation GSM	203 and 208
61	E2012	Second generation GSM	154 and 210
62	E2212	Second generation GSM	211
63	BMS-869780	Second generation GSM	214
64	BMS-932481	Second generation GSM	154
65	PF-06648671	Second generation GSM	215
66	SPI-014	Second generation GSM	217
67	SPI-1865	Second generation GSM	217
68	Dihydroergocristine	Second generation GSM	219
69	Acitretin	α-Secretase activator	223
70	Etazolate (EHT-0202)	GABAA modulator & α-secretase activator	225
71	PF-05212377 (SAM-760)	Selective 5-HT6R antagonist	57 and 231
72	Iadalopirdine	Selective 5-HT6R antagonist	233
73	Varoglutamstat (PQ-912)	QC inhibitor	235
74	Etanercept	Competitive TNF-α inhibitor	243
75	Thalidomide	Immunomodulator & TNF-α inhibitor	244
76	Muscimol	GABAA agonist	250
77	Propofol	GABAA agonist	250
78	SGS742 (CGP36742)	GABAB antagonist	251
79	CGP55845	GABAB antagonist	254
80	Vitamin E	Antioxidant	257 and 258
81	Caffeine	Antioxidant	261
82	Silibinin	Antioxidant	262
83	Curcumin	Antioxidant	263
84	Quercetin	Antioxidant	264
85	Luteolin	Antioxidant	265
86	α-Lipoic acid	Mitochondrial-targeted antioxidant	261 and 266
87	Coenzyme Q10	Mitochondrial-targeted antioxidant	261
88	Melatonin	Antioxidant	267–271
89	Selegiline	Antioxidant	258 and 261